Previous Close | 26.29 |
Open | 27.33 |
Bid | 27.40 x 300 |
Ask | 27.49 x 600 |
Day's Range | 26.98 - 27.92 |
52 Week Range | 24.60 - 63.57 |
Volume | |
Avg. Volume | 1,571,819 |
Market Cap | 3.29B |
Beta (5Y Monthly) | 1.89 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.24 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 41.23 |
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.
10x Genomics ( NASDAQ:TXG ) First Quarter 2024 Results Key Financial Results Revenue: US$141.0m (up 5.0% from 1Q 2023...
10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript April 30, 2024 10x Genomics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day everyone and welcome to the 10x Genomics First Quarter 2024 Earnings Call. Today’s call is […]